This website uses technical, customisation and analytical cookies, both first-party and third-party, to anonymously facilitate browsing and analyse statistics on use of the website. Learn more
Search results
-
PAREXEL International Corp.: Stages of Innovation
Herzlinger, Regina E.; Kindred, NatalieCase HBS-314056-EThrough the lens of biopharmaceutical contract research organization (CRO) PAREXEL, this case traces the evolution of the firm as it reinvents itself in response to the transformation of the CRO sector from a small, secondary cluster of firms into a majorStarting at €8.20
-
La-Z-Boy (A)
Fuller, Joseph B.; Kindred, NatalieCase HBS-317034-EStrategyKurt Darrow, CEO of La-Z-Boy furniture, must decide whether to continue an overhaul of the company's strategy in the face of a collapse in demand during the great recession. Having pared back La-Z-Boy's portfolio of brands and manufacturing network, he intends to reposition the company as a branded retailer of furniture and home fashions. Just management is poised to implement a new strategy that involves a heavy investment in brand advertising, ...Starting at €8.20
-
Acibadem Healthcare Group
Herzlinger, Regina E.; Cekin, Esel; Kindred, Natalie; Yucaoglu, GamzeCase HBS-315120-EThis case focuses on Ac badem Healthcare Group's, Turkey's only premium nationwide hospital network, potential expansion strategies after it was acquired by International Healthcare Holdings Berhad (IHH) in 2011, the world's second-largest publicly listed health care group and a private hospital leader in Singapore and Malaysia. By providing perspectives on both Ac badem and IHH-Parkway-Pantai's operational models, growth aspirations, collabora...Starting at €8.20
-
Shanghai Pharmaceuticals
Herzlinger, Regina E.; Kindred, NatalieCase HBS-313016-EStrategyShanghai Pharmaceuticals (SPH), a vertically integrated Chinese pharmaceutical conglomerate, was considering its strategic options in the context of a rapidly evolving industry, policy, and economic environment. The company-essentially a collection of subsidiaries operating under a unified management structure-was formed through the 2009 merger of several state-owned enterprises, part of a broad policy effort in China to streamline state assets, ...Starting at €8.20
-
Cancer Treatment Centers of America (A)
Herzlinger, Regina E.; Kindred, NatalieCase HBS-313012-EService and Operations ManagementCancer Treatment Centers of America (CTCA), a U.S. network of four privately owned oncology focused factory hospitals, was weighing options for growth. CTCA was entirely cancer focused and specialized in treating patients with complex and advanced-stage cancers, who were reached through advertising its integrative, team-based approach to care. CEO Stephen Bonner needed to decide whether to focus future expansion on building additional full-scale ...Starting at €8.20
-
McKesson
Herzlinger, Regina E.; Kindred, NatalieCase HBS-312002-EMcKesson, a large, diversified drug distribution and health care IT company, is considering development of new business offerings to help private practice physicians remain independent. The company, with $122 billion in 2010 revenues, just made its first foray into health care services with the acquisition of U.S. Oncology, an integrated cancer care company, whose expertise it could leverage in offerings catered to other physician specialties. Wi...Starting at €8.20
-
Henkel: Building a Winning Culture (B)
Simons, Robert L.; Kindred, NatalieCase HBS-115040-ELeadership and People ManagementThis case, an update on "Henkel: Building a Winning Culture (A)," describes Henkel's strong performance against its tough 2012 objectives, as well as the new objectives CEO Kasper Rorsted set for 2016.Starting at €5.74
-
-
Merck: Managing Vioxx (A)-(G), Teaching Note
Kindred, Natalie; Simons, Robert L.Teaching Note HBS-109087-ETeaching Note for [109080], [109081], [109082], [109083], [109084], [109085], and [109086].Starting at €0.00
-
Merck: Managing Vioxx (A)
Simons, Robert L.; Rosenberg, Kathryn; Kindred, NatalieCase HBS-109080-EKnowledge and CommunicationThis two-class case series allows students to stand in the shoes of CEO Ray Gilmartin during the unfolding stages of a reputational crisis. Merck's mission statement claims to "put patients first," but the company is widely criticized for putting profit bStarting at €8.20